Genomic and transcriptomic determinants of clinical outcomes in patients with AML and DNMT3A mutations.
Ni SC, Yao CY, Tsai XC, Lo MY, Chen CY, Lee WH, Lin CC, Kuo YY, Peng YL, Tseng MH, Wu YS, Liu MC, Lin LI, Chuang MK, Ko BS, Yao M, Tang JL, Tien FM, Chou WC, Hou HA, Tien HF.
Ni SC, et al. Among authors: liu mc.
Blood Cancer J. 2025 May 20;15(1):97. doi: 10.1038/s41408-025-01287-9.
Blood Cancer J. 2025.
PMID: 40389402
Free PMC article.